IDiyas

For the Inventor, By the Inventor

Krefeld, Germany

Hans-Georg Heine

USPTO Granted Patents = 47

Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 228(Granted Patents)


Location History:

  • Krefeld-Verdingen, DE (1981)
  • Krefeld, DE (1976 - 2001)

Company Filing History:

goldMedal46 out of 12,157 
 
Bayer Aktiengesellschaft
 patents
silverMedal1 out of 6,850 
 
Ciba-geigy Corporation
 patents

Years Active: 1976-2001

Loading Chart...
47 patents (USPTO):Explore Patents
1. 6194428 - Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system (2001-02-27),
2. 6147087 - Use of 1,2-Bridged 1,4-dihydropyridines as medicaments (2000-11-14),
3. 6121284 - 2,3-bridged 1,4-dihydropyridines, and their use as medicaments (2000-09-19),
4. 6060482 - Triazaspirodecanone-methylchromans (2000-05-09),
5. 5990121 - Use of 1,2-bridged 1,4-dihydropyridines as medicaments (1999-11-23),
6. 5962513 - 2-aminomethyl-chromans effective in the treatment of psychoses and (1999-10-05),
7. 5955482 - Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments (1999-09-21),
8. 5942529 - Benzisothiazolyl-substituted aminomethylchromans (1999-08-24),
9. 5942526 - 5-acyl-1,4-dihydropyridines (1999-08-24),
10. 5874462 - Use of substituted 6-amino-4H-pyrans (1999-02-23),
11. 5861394 - Use of N-substituted phenothiazines (1999-01-19),
12. 5760073 - Substituted 4H-pyrans (1998-06-02),
13. 5756515 - Dioxo-thiopyrano-pyridine-carboxylic acid derivatives and their use as (1998-05-26),
14. 5719181 - Use of acyl-substituted aminopyrans (1998-02-17),
15. 5696137 - Azaheterocyclymethyl-chromans (1997-12-09),

Title: The Innovative Contributions of Hans-Georg Heine

Introduction: Hans-Georg Heine, a notable inventor based in Krefeld, Germany, has made significant advancements in the field of medicinal chemistry. With an impressive portfolio of 47 patents, Heine's work focuses on developing novel compounds for treating diseases of the central nervous system.

Latest Patents: Among his latest inventions are two noteworthy patents. The first patent pertains to the use of 5-substituted pyridine and hexahydroquinoline-3-carboxylic acid derivatives for treating diseases of the central nervous system. This invention outlines the production of medicaments specifically aimed at addressing cerebral disorders. The second patent involves the use of 1,2-bridged 1,4-dihydropyridines as medicinal agents. This invention emphasizes their role as selective potassium channel modulators, particularly in the treatment of conditions related to the central nervous system.

Career Highlights: Throughout his career, Hans-Georg Heine has collaborated with prominent companies such as Bayer Aktiengesellschaft and Ciba-Geigy Corporation, where he contributed to significant research and development projects. His extensive work has paved the way for new therapeutic strategies in neurology.

Collaborations: Heine has also worked alongside notable colleagues, including Thomas Glaser and Henning Sommermeyer. Their joint efforts have enhanced the scope of research initiatives and have facilitated innovative approaches to medicinal chemistry.

Conclusion: Hans-Georg Heine stands out as a leading inventor in the pharmaceutical industry, with a strong focus on developing treatments for neurological disorders. His continued innovation and collaboration with reputable companies and talented individuals underscore the impact of his work, making significant strides in enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…